Bronconex Acticap

Ország: Új-Zéland

Nyelv: angol

Forrás: Medsafe (Medicines Safety Authority)

Aktív összetevők:

Mometasone furoate 200ug (anhydrous)

Beszerezhető a:

Organon (New Zealand) Limited

INN (nemzetközi neve):

Mometasone furoate 200 µg (anhydrous)

Adagolás:

200 mcg/dose

Gyógyszerészeti forma:

Powder for inhalation

Összetétel:

Active: Mometasone furoate 200ug (anhydrous) Excipient: Lactose

db csomag:

Inhaler, metered, DPI, (sample), 14 dose units

Osztály:

Prescription

Recept típusa:

Prescription

Gyártó:

MSD International GmbH (Singapore Branch)

Terápiás javallatok:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Termék összefoglaló:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 120 dose units - 18 months from date of manufacture stored at or below 25°C

Engedély dátuma:

2000-12-05